S.E. Marrón

3.6k total citations · 1 hit paper
55 papers, 1.5k citations indexed

About

S.E. Marrón is a scholar working on Dermatology, Immunology and Surgery. According to data from OpenAlex, S.E. Marrón has authored 55 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 40 papers in Dermatology, 11 papers in Immunology and 8 papers in Surgery. Recurrent topics in S.E. Marrón's work include Dermatology and Skin Diseases (26 papers), Hidradenitis Suppurativa and Treatments (10 papers) and Allergic Rhinitis and Sensitization (8 papers). S.E. Marrón is often cited by papers focused on Dermatology and Skin Diseases (26 papers), Hidradenitis Suppurativa and Treatments (10 papers) and Allergic Rhinitis and Sensitization (8 papers). S.E. Marrón collaborates with scholars based in Spain, Ukraine and Italy. S.E. Marrón's co-authors include L. Tomás-Aragonés, A.Y. Finlay, Lucía Tomás Aragonés, Jacek C. Szepietowski, Francesca Sampogna, Sam Salek, F. Poot, Pavel V. Chernyshov, Andrea W.M. Evers and Gregor B. E. Jemec and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Journal of Investigative Dermatology.

In The Last Decade

S.E. Marrón

53 papers receiving 1.5k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

The Psychological Burden of Skin Diseases: A Cross-Sectional Multicenter Study among Dermatological Out-Patients in 13 European Countries

2014 612 citations Florence Dalgard, Uwe Gieler et al. Journal of Investigative Dermatology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
S.E. Marrón Spain	18	1.1k	309	228	193	175	55	1.5k
F. Poot Belgium	17	848 0.8×	303 1.0×	193 0.8×	117 0.6×	253 1.4×	34	1.3k
İlknur Kıvanç Altunay Türkiye	16	993 0.9×	414 1.3×	172 0.8×	147 0.8×	205 1.2×	123	1.7k
Florence Dalgard Norway	14	1.1k 1.0×	283 0.9×	254 1.1×	69 0.4×	191 1.1×	21	1.5k
Dennis Linder Italy	24	1.1k 1.0×	590 1.9×	200 0.9×	116 0.6×	202 1.2×	55	1.9k
Jon Anders Halvorsen Norway	11	970 0.9×	259 0.8×	243 1.1×	59 0.3×	145 0.8×	16	1.3k
Lucía Tomás Aragonés Spain	8	563 0.5×	226 0.7×	158 0.7×	69 0.4×	171 1.0×	15	901
Alejandro Molina‐Leyva Spain	24	1.0k 1.0×	263 0.9×	100 0.4×	483 2.5×	57 0.3×	130	1.6k
Joanna Salomon Poland	14	545 0.5×	297 1.0×	117 0.5×	72 0.4×	93 0.5×	26	867
E. Brenaut France	22	986 0.9×	538 1.7×	242 1.1×	60 0.3×	62 0.4×	87	1.7k
Flora Balieva Norway	7	523 0.5×	235 0.8×	153 0.7×	56 0.3×	119 0.7×	11	768

Countries citing papers authored by S.E. Marrón

Since Specialization

Citations

This map shows the geographic impact of S.E. Marrón's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by S.E. Marrón with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites S.E. Marrón more than expected).

Fields of papers citing papers by S.E. Marrón

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by S.E. Marrón. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by S.E. Marrón. The network helps show where S.E. Marrón may publish in the future.

Co-authorship network of co-authors of S.E. Marrón

This figure shows the co-authorship network connecting the top 25 collaborators of S.E. Marrón. A scholar is included among the top collaborators of S.E. Marrón based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with S.E. Marrón. S.E. Marrón is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Chernyshov, Pavel V., Francesca Sampogna, Christos C. Zouboulis, et al.. (2024). Development of the acne-specific quality of life questionnaire Quality of Life Relevance-Acne. JAAD International. 16. 9–17. 3 indexed citations

Chernyshov, Pavel V., Christos C. Zouboulis, S.E. Marrón, et al.. (2024). Short Version of the Quality of Life Relevance-Acne Questionnaire. Dermatology. 240(5-6). 1–5.

Chernyshov, Pavel V., S.E. Marrón, Dimitra Koumaki, et al.. (2023). Responsiveness and Minimal Clinically Important Difference of the Infants and Toddlers Dermatology Quality of Life Questionnaire. Dermatology and Therapy. 13(11). 2879–2893. 3 indexed citations

Chernyshov, Pavel V., L. Tomás-Aragonés, L. Manolache, et al.. (2023). Bullying in persons with skin diseases. Journal of the European Academy of Dermatology and Venereology. 38(4). 752–760. 8 indexed citations

Paller, Amy S., S.E. Marrón, Diane Whalley, et al.. (2023). Clinically meaningful change threshold in health‐related quality of life among patients aged 6 months to 5 years with atopic dermatitis and their caregiver(s)/family. SHILAP Revista de lepidopterología. 3(1). 253–257. 1 indexed citations

Chernyshov, Pavel V., Francesca Sampogna, Christos C. Zouboulis, et al.. (2022). Which Health-Related Quality of Life Items Most Affect Acne Patients?. Dermatology. 239(2). 267–272. 5 indexed citations

Chernyshov, Pavel V., Andrea W.M. Evers, Anthony Bewley, et al.. (2021). Quality of life assessment in core outcome sets: A position statement of the EADV Task Force on Quality of Life and Patient Oriented Outcomes. Journal of the European Academy of Dermatology and Venereology. 36(1). 20–23. 7 indexed citations

Krajewski, Piotr K., et al.. (2021). The Use of HSQoL-24 in an Assessment of Quality-of-Life Impairment among Hidradenitis Suppurativa Patients: First Look at Real-Life Data. Journal of Clinical Medicine. 10(22). 5446–5446. 5 indexed citations

Chernyshov, Pavel V., S.E. Marrón, L. Tomás-Aragonés, et al.. (2020). Initial validation of the epidermolysis bullosa‐specific module of the Infants and Toddlers Dermatology Quality of Life questionnaire. Dermatologic Therapy. 33(6). e14128–e14128. 7 indexed citations

10.

Chernyshov, Pavel V., Swen Malte John, L. Tomás-Aragonés, et al.. (2020). Quality of life measurement in occupational skin diseases. Position paper of the European Academy of Dermatology and Venereology Task Forces on Quality of Life and Patient Oriented Outcomes and Occupational Skin Disease. Journal of the European Academy of Dermatology and Venereology. 34(9). 1924–1931. 13 indexed citations

11.

Finlay, A.Y., Pavel V. Chernyshov, L. Tomás-Aragonés, et al.. (2020). Methods to improve quality of life, beyond medicines. Position statement of the European Academy of Dermatology and Venereology Task Force on Quality of Life and Patient Oriented Outcomes. Journal of the European Academy of Dermatology and Venereology. 35(2). 318–328. 18 indexed citations

12.

Chernyshov, Pavel V., L. Tomás-Aragonés, Matthias Augustin, et al.. (2020). Position statement of the European Academy of Dermatology and Venereology Task Force on Quality of Life and Patient Oriented Outcomes on quality of life issues in dermatologic patients during the COVID‐19 pandemic. Journal of the European Academy of Dermatology and Venereology. 34(8). 1666–1671. 22 indexed citations

13.

Chernyshov, Pavel V., L. Tomás-Aragonés, Francesca Sampogna, et al.. (2020). Selection process of measures for core outcome set should utilize the highest methodology level and should be maximally free of bias. Comment on ‘IDQoL, CDLQI and the 45‐item CADIS received a sufficient content validity rating during the HOME VII meeting in Japan: a group discussion study’. Journal of the European Academy of Dermatology and Venereology. 35(3). e208–e209. 2 indexed citations

14.

Marrón, S.E., L. Tomás-Aragonés, Carmen Rodríguez‐Cerdeira, et al.. (2019). Body dysmorphic disorder in patients with acne: a multicentre study. Journal of the European Academy of Dermatology and Venereology. 34(2). 370–376. 25 indexed citations

15.

Chernyshov, Pavel V., et al.. (2019). International pilot tests of the epidermolysis bullosa‐specific module of the Infants and Toddlers Dermatology Quality of Life questionnaire. Journal of the European Academy of Dermatology and Venereology. 34(3). e123–e124. 4 indexed citations

16.

Balieva, Flora, A.Y. Finlay, J. Küpfer, et al.. (2018). The Role of Therapy in Impairing Quality of Life in Dermatological Patients: A Multinational Study. Acta Dermato Venereologica. 98(6). 563–569. 16 indexed citations

17.

Marrón, S.E., et al.. (2018). Detección de trastorno dismórfico corporal en pacientes con acné: estudio piloto. Actas Dermo-Sifiliográficas. 110(1). 28–32. 13 indexed citations

18.

Puig, L., G. Carretero, E. Daudén, et al.. (2015). Biosimilares en dermatología. Situación actual (parte ii). Actas Dermo-Sifiliográficas. 106(7). 550–554. 4 indexed citations

19.

Carrascosa, J.M., M. García‐Bustinduy, Eduardo Fonseca, et al.. (2011). Perfil clínico y curso evolutivo de los pacientes tratados con efalizumab tras la suspensión de su autorización por la EMEA. Estudio observacional y multicéntrico. Actas Dermo-Sifiliográficas. 102(5). 354–364. 1 indexed citations

20.

Marrón, S.E.. (1997). Treatment of acne scars. Journal of Investigative Dermatology. 3(108). 396. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact